- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/51 - Lyases (4)
Patent holdings for IPC class A61K 38/51
Total number of patents in this class: 426
10-year publication summary
33
|
35
|
48
|
48
|
38
|
43
|
35
|
45
|
25
|
26
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of Colorado, a body corporate | 2609 |
26 |
Board of Regents, The University of Texas System | 5751 |
17 |
Codexis, Inc. | 796 |
13 |
Seikagaku Corporation | 189 |
13 |
The Regents of the University of California | 19812 |
10 |
Erytech Pharma | 68 |
10 |
Thornhill Therapeutics, Inc. | 28 |
9 |
Voyager Therapeutics, Inc. | 256 |
8 |
Glyscend, Inc. | 24 |
8 |
BioMarin Pharmaceutical Inc. | 378 |
6 |
AERase, Inc. | 18 |
5 |
Kolon Life Science, Inc. | 42 |
5 |
Meiragtx UK II Limited | 68 |
5 |
Guangzhou Sinogen Pharmaceutical Co., Ltd | 25 |
5 |
Synlogic Operating Company, Inc. | 114 |
5 |
Syntis bio, Inc. | 10 |
5 |
Acorda Therapeutics, Inc. | 125 |
4 |
Denovo Biopharma, LLC | 32 |
4 |
Regeneron Pharmaceuticals, Inc. | 4223 |
4 |
William Marsh Rice University | 999 |
4 |
Other owners | 260 |